Activation is a prospective randomised (1 :1) controlled study to test the hypothesis that revascularisation of significant coronary artery disease by Percutaneous Coronary Intervention prior to Transcatheter Aortic Valve Implantation (TAVI) will result in rate of mortality and re-hospitalisation at 12 months that is non-inferior to TAVI without such revascularisation.
Composite of mortality and rehospitalisation at 12 months
Clinical trial documentation,
eCRF / data-management,
France, Germany, United Kingdom
17 investigational centers